Sign in

CIK 0001728117

  • Non-accelerated filer
  • Smaller reporting company

Gossamer Bio, Inc.

Sign in to watch
Ticker
GOSS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
475461709
Phone
+1 858-684-1300
Business address
3115 MERRYFIELD ROW, SUITE 120, SAN DIEGO, CA, 92121
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 6 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-19 Aranda Richard Chief Medical Officer Returned to the company · Stock Option (Right to Buy) −562,500 0
2026-03-19 Aranda Richard Chief Medical Officer Returned to the company · Stock Option (Right to Buy) −572,000 0
2026-03-19 Aranda Richard Chief Medical Officer Returned to the company · Stock Option (Right to Buy) −487,500 0
2026-03-19 Aranda Richard Chief Medical Officer Returned to the company · Stock Option (Right to Buy) −162,500 0
2026-03-19 Aranda Richard Chief Medical Officer Returned to the company · Stock Option (Right to Buy) −157,500 0
2026-03-19 Aranda Richard Chief Medical Officer Returned to the company · Stock Option (Right to Buy) −157,500 0
2026-03-19 Aranda Richard Chief Medical Officer Returned to the company · Stock Option (Right to Buy) −126,667 0
2026-03-19 Aranda Richard Chief Medical Officer Returned to the company · Stock Option (Right to Buy) −20,000 0
2026-03-19 Aranda Richard Chief Medical Officer Returned to the company · Stock Option (Right to Buy) −40,000 0
2026-03-19 Aranda Richard Chief Medical Officer Returned to the company · Stock Option (Right to Buy) −22,784 0
2026-03-19 Aranda Richard Chief Medical Officer Returned to the company · Stock Option (Right to Buy) −9,167 0
2026-03-19 Aranda Richard Chief Medical Officer Returned to the company · Stock Option (Right to Buy) −30,000 0
2026-03-19 Aranda Richard Chief Medical Officer Grant or award · Stock Option (Right to Buy) +562,500 562,500
2026-03-19 Aranda Richard Chief Medical Officer Grant or award · Stock Option (Right to Buy) +572,000 572,000
2026-03-19 Aranda Richard Chief Medical Officer Grant or award · Stock Option (Right to Buy) +487,500 487,500
2026-03-19 Aranda Richard Chief Medical Officer Grant or award · Stock Option (Right to Buy) +162,500 162,500
2026-03-19 Aranda Richard Chief Medical Officer Grant or award · Stock Option (Right to Buy) +157,500 157,500
2026-03-19 Aranda Richard Chief Medical Officer Grant or award · Stock Option (Right to Buy) +157,500 157,500
2026-03-19 Aranda Richard Chief Medical Officer Grant or award · Stock Option (Right to Buy) +126,667 126,667
2026-03-19 Aranda Richard Chief Medical Officer Grant or award · Stock Option (Right to Buy) +20,000 20,000

Page 1 of 3 · 55 trades